BAFNA PHARMACEUTICALS LTD. | Scrip Code : 532989 | Quarter ending :September 2016 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 8 | 62,35,731 | 62,35,731 | 33.42 | 62,35,731 | 33.42 | 21,12,650 | 33.88 | 62,35,731 | - | - | - | (B) Public | 9,830 | 1,24,20,604 | 1,24,20,604 | 66.58 | 1,24,20,604 | 66.58 | | 0.00 | 1,22,95,329 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 9,838 | 1,86,56,335 | 1,86,56,335 | 100.00 | 1,86,56,335 | 100.00 | 21,12,650 | 11.32 | 1,85,31,060 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|